| GRANT | DATE | AMOUNT | PROGRAM |
|---|---|---|---|
|
Children's Hospital Corporation
A sustainable gut single-cell atlas to advance understanding and treatment of Crohn's disease. |
01.12.2026 | $643,491.00 | Crohn's Disease, Disease Biology |
|
Children's Hospital Corporation
IL23R-Base-Edited Autologous HSC Therapy for Refractory Crohn's Disease |
01.12.2026 | $1,980,000.00 | Crohn's Disease, Therapeutics |
|
University of Nottingham
UK Crohn's Disease MAMS Trial Development |
01.12.2026 | $139,307.00 | Crohn's Disease, Therapeutics |
|
Mass General Brigham for the Massachusetts General Hospital
Crohn's and Ulcerative colitis: Results for older adults |
12.03.2025 | $861,492.00 | Crohn's Disease, Disease Management |
|
Cornell University for the Joan & Sanford I. Weill Medical College of Cornell University
“Is Kono-S Anastomosis Protective of Surgical & Endoscopic Recurrence in Crohn's Disease? 10-Year RCT.” |
11.19.2025 | $1,402,545.00 | Crohn's Disease, Disease Management |
|
Regents of The University of Michigan
The SYMPTOM Trials: Scalable, community-based methods for persistent IBS-like symptoms in Crohn's Disease in remission. |
11.19.2025 | $2,498,429.00 | Crohn's Disease, Therapeutics |
|
The Regents of the University of Colorado, Denver
Identifying Facilitators and Barriers to Close Disease Activity Monitoring in Treat-to-Target care in Crohn's Disease. |
11.19.2025 | $1,269,877.00 | Crohn's Disease, Disease Management |
|
Children's Hospital Corporation
Identifying Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease-(Boston Studies) |
11.05.2025 | $2,261,115.00 | Crohn's Disease, Prevention |
|
Cedars-Sinai Medical Center
Integrative Multi-Omic and Computational Characterization to Identify Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease and Across IBD Populations |
11.05.2025 | $222,750.00 | Crohn's Disease, Prevention |
|
Katholieke Universiteit te Leuven
Reprogramming epithelial plasticity and inflammatory architecture in pCD fistula (REPAIR-CD) |
11.05.2025 | $2,602,379.00 | Crohn's Disease, Disease Biology |
|
Care-for-Rare America Inc
Mechanism-Based Patient Stratification and Therapeutic Target Discovery - Munich VEOIBD Program |
11.05.2025 | $1,791,671.00 | Crohn's Disease, Prevention |
|
Children's Hospital Medical Center
Towards an Improved Understanding of Stricturing Pediatric Small Bowel Crohn's Disease and a Standardized Definition |
11.05.2025 | $2,072,212.00 | Crohn's Disease, Diagnostics |
|
The Hospital for Sick Children
Identifying Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease (Toronto Studies) |
10.21.2025 | $1,642,365.00 | Crohn's Disease, Prevention |
|
Sage Bionetworks
Enabling FAIR Data Governance and Coordination to Enhance Mechanistic Origins and Clinical Impact Discovery in VEOIBD |
10.21.2025 | $222,750.00 | Crohn's Disease, Prevention |
|
The Cleveland Clinic Foundation
Radiomics-based machine learning for stratification of Crohn's disease strictures on magnetic resonance enterography |
10.21.2025 | $2,725,254.00 | Crohn's Disease, Diagnostics |
|
Chancellor Masters & Scholars Of The University Of Oxford
Targeting Immunological Niches in VEO-IBD: From Genes to Therapies |
10.21.2025 | $1,039,500.00 | Crohn's Disease, Prevention |
|
Icahn School Of Medicine At Mount Sinai
Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease: multiomic insights leveraging diverse populations and myeloid-stromal cross-talk |
10.21.2025 | $594,000.00 | Crohn's Disease, Prevention |
|
Crohn's & Colitis Foundation, Inc.
2026 Support for the Crohn's & Colitis Congress presented by the Crohn's & Colitis Foundation and the American Gastroenterological Association |
10.21.2025 | $235,000.00 | Crohn's Disease, Disease Management |
|
Mass General Brigham for the Brigham and Women's Hospital, Inc.
Mechanisms of fibroblast inflammatory and fibrogenic transitions in Crohn's disease |
10.21.2025 | $1,505,189.00 | Crohn's Disease, Disease Biology |
|
University of Otago
Evaluation of fecal myeloperoxidase as an accurate and rapid clinical test in Inflammatory Bowel Disease |
10.06.2025 | $1,390,086.00 | Crohn's Disease, Disease Management |
|
Prev
12...16
Next
1 - 20 of 319 results
|
|||